MST CONTINUS TABLET 100MG

国: マレーシア

言語: 英語

ソース: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

有効成分:

MORPHINE SULPHATE

から入手可能:

MUNDIPHARMA PHARMACEUTICALS SDN. BHD.

INN（国際名）:

MORPHINE SULPHATE

パッケージ内のユニット:

60 Tablet Tablets; 30Tablet Tablets

製:

BARD PHARM LTD

製品の特徴

_MST CONTINUS_
®
TABLETS
NAME OF THE MEDICINAL PRODUCT
_MST CONTINUS_
®
10 mg, 30 mg, 60 mg, 100 mg Prolonged Release Tablets
QUALITATIVE AND QUANTITATIVE COMPOSITION
Tablets containing Morphine Sulfate Ph.Eur, 10 mg, 30 mg, 60 mg, 100
mg.
PHARMACEUTICAL FORM
Prolonged release, film-coated, biconvex tablets, plain on one side
and the strength of the preparation is marked on
the other.
_MST CONTINUS_
®
tablets 10 mg are golden brown.
_MST CONTINUS_
®
tablets 30 mg are purple.
_MST CONTINUS_
®
tablets 60 mg are orange.
_MST CONTINUS_
®
tablets 100 mg are grey.
CLINICAL PARTICULARS
THERAPEUTIC INDICATIONS
Prolonged relief of severe pain
POSOLOGY AND METHOD OF ADMINISTRATION
Route of administration: oral
_MST CONTINUS_
®
tablets should be swallowed whole and not broken, chewed or crushed.
The administration of
broken, chewed or crushed tablets may lead to a rapid release and
absorption of a potentially fatal dose of morphine
(refer to
_Overdose)_
.
_MST CONTINUS_
®
tablets should be used at 12-hourly intervals. The dosage is dependent
upon the severity of the
pain, the patient's age and previous history of analgesic
requirements.
Drug product is not recommended preoperatively or within the first 24
hours postoperatively.
Adults:
A patient presenting with severe pain, uncontrolled by weaker opioids
(e.g. dihydrocodeine) should normally be
started on 30 mg 12 hourly. Patients previously on normal release oral
morphine should be given the same total
daily dose as
_MST CONTINUS_
®
tablets but in divided doses at 12-hourly intervals.
Increasing severity of pain will require an increased dosage of the
tablets. Higher doses should be made, where
possible in 30-50% increments as required. The correct dosage for any
individual patient is that which is sufficient
to control pain with no, or tolerable, side effects for a full 12
hours. It is recommended that the 200 mg strength is
reserved for patients who have already been titrated to a stable
analgesic dose using lower strengths of morphine or
other opioid preparatio